Research theme for competitive and other funds (8):
2021 - 2026 トリプレットリピート病のリピート長変動機構解明とリピート短縮治療の基盤確立
2019 - 2022 トリプレットリピート病のリピート短縮による根源的治療法の開発
2016 - 2020 筋強直性ジストロフィーの包括的治療法確立
2014 - 2018 Chemical Biology Studies on Trinucleotide Repeat Disease using Repeat-Binding Molecules
2014 - 2017 Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
2015 - 2017 Allele specific inhibition of mutant mRNA expression for repeat expansion disorders
2013 - 2015 Modulation of repeat size in trinucleotide repeat expansion disorders
2012 - 2013 トリプレットリピート病におけるリピート伸長機構の解明と制御
Show all
Papers (99):
Masayuki Nakamori, Daisaku Nakatani, Tomoharu Sato, Yuhei Hasuike, Seiko Kon, Toshio Saito, Harumasa Nakamura, Masanori P. Takahashi, Eisuke Hida, Hirofumi Komaki, et al. Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. eClinicalMedicine. 2024. 67. 102390-102390
Masayuki Nakamori. Expanded-repeat-RNA-mediated disease mechanisms in myotonic dystrophy. Neurology and Clinical Neuroscience. 2024
Eitaro Murakami, Masayuki Nakamori, Kazuhiko Nakatani, Tomonori Shibata, Kazuki Tainaka. Intracerebral Distribution of CAG Repeat-Binding Small Molecule Visualized by Whole-Brain Imaging. Bioconjugate chemistry. 2023. 34. 12. 2187-2193
Masaya Honda, Fumitaka Shimizu, Ryota Sato, Masayuki Nakamori. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies. Journal of neuromuscular diseases. 2023
Kazuki Yoshizumi, Masamitsu Nishi, Masataka Igeta, Masayuki Nakamori, Kimiko Inoue, Tsuyoshi Matsumura, Harutoshi Fujimura, Kenji Jinnai, Takashi Kimura. Analysis of splicing abnormalities in the white matter of myotonic dystrophy type 1 brain using RNA sequencing. Neuroscience research. 2023
T. Uehara, C. J. Choong, H. Hayakawa, Y. Kasahara, T. Nagata, T. Yokota, K. Baba, M. Nakamori, S. Obika, H. Mochizuki. Antisense Oligonucleotides Containing Amido-Bridged Nucleic Acid Downregulate SNCA Expression and Improve Motor Function in Parkinson's disease Mouse Models. MOVEMENT DISORDERS. 2017. 32